|All Peptides

Read the full guides

Gonadorelin

Last reviewed: July 30, 2026 by The Peptide Catalog Team

A synthetic GnRH decapeptide that acts on the pituitary to release LH and FSH; pulsatile delivery stimulates the axis while continuous exposure downregulates it, and the clinical efficacy data comes from pump-delivered pulsatile dosing. Synthetic GnRH decapeptide that signals the pituitary to release LH and FSH.

Overview

Gonadorelin Results Timeline

Progression
1
Minutes after a dose
Physical Changes
The pharmacologic window is brief — distribution half-life is roughly 2-10 minutes, terminal 10-40 minutes
Performance & Recovery
Any LH/FSH response happens inside this window, not as a felt effect
Other Benefits
Effects are read on gonadotropin labs, not sensation
2
Pulsatile delivery
Physical Changes
Physiologic pulses every 60-120 minutes are the pattern that stimulates LH and FSH
Performance & Recovery
This is the pattern the pump-delivered clinical data used
Other Benefits
Community subcutaneous schedules do not reproduce it
3
Continuous exposure
Physical Changes
The GnRH receptor downregulates and LH/FSH are suppressed rather than raised
Performance & Recovery
This is the deliberate mechanism behind GnRH-agonist chemical castration
Other Benefits
Direction of effect is set by delivery pattern, not by dose size
4
Honest read
Physical Changes
No controlled trial has evaluated the twice-weekly subcutaneous schedule common in community use
Performance & Recovery
The congenital hypogonadotropic hypogonadism pump data does not transfer to it
Other Benefits
A research compound — no FDA-approved community protocol exists

Timeline is illustrative and non-guaranteed. Outcomes vary and are commonly discussed alongside training, nutrition, sleep, and cycling practices.

How It WorksSynthetic GnRH Decapeptide — Pituitary Gonadotropin Secretagogue

Receptor → GnRH Cascade → Hormone Production → Outcomes

1
Target

GnRH Receptor (GnRHR) on Pituitary Gonadotrophs

Gonadorelin is synthetic gonadotropin-releasing hormone — the decapeptide pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, identical to the hypothalamic hormone. It binds the GnRH receptor (GnRHR), a Gq/11-coupled GPCR expressed on gonadotroph cells of the anterior pituitary. That places it one step above HCG in the reproductive cascade: HCG acts directly on testicular Leydig cells, while gonadorelin signals the pituitary and lets the pituitary do the work.

2
Cellular Signal

Gq/11 → Phospholipase C → LH and FSH Release

Receptor binding activates Gq/11 and the phospholipase C pathway inside the gonadotroph, which drives release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The signal is short-lived by design: gonadorelin has a distribution half-life of roughly 2-10 minutes and a terminal half-life of about 10-40 minutes.

3
Systemic Effect

Delivery Pattern Decides Stimulation vs Suppression

This is the central point of the compound. Pulsatile exposure — the physiologic pattern, roughly every 60-120 minutes — stimulates LH and FSH release. Continuous exposure does the opposite: the GnRH receptor downregulates and LH/FSH are suppressed. That suppression is not a side effect but the deliberate mechanism behind GnRH-agonist chemical castration. The same molecule produces opposite outcomes depending on how it is delivered.

4
What You Notice

Bloodwork, Not Sensation

Any effect is read on gonadotropin and downstream sex-hormone labs rather than felt directly. Published efficacy data comes from pump-delivered pulsatile GnRH in congenital hypogonadotropic hypogonadism, not from the twice-weekly subcutaneous schedule common in community use — so that data should not be read as predicting what a community protocol does.

What Makes This Peptide Different

Gonadorelin is synthetic GnRH itself, not an analog — which makes it the most upstream compound in this category. Where HCG substitutes for LH at the gonad and kisspeptin acts above the hypothalamus to trigger endogenous GnRH release, gonadorelin acts at the pituitary in between. Its defining and most misunderstood property is that the direction of its effect is set by dosing pattern, not dose size: pulsatile stimulates, continuous suppresses.

Gonadorelin Vendors

COA

Swiss Chems

Score
10/10
Price
$24.95
Amount
2mg
Cost/mg
$12.47/mg
Ships Worldwide
View at Swiss Chems
Dosing ProtocolHPG-Axis Support (Research / No Validated Community Dose)

Educational reference only. Individual responses vary. Consult healthcare provider before use.

Vial Size
2 mg
Reconstitution
2 ml BAC water (1,000 mcg/ml)
Dose
100 mcg (10 units on 1ml syringe) — community convention, not a trial dose
Timing
Consistent time of day
Frequency
Community use is commonly 2x per week
Duration
Ongoing in community protocols; no validated course length
Protocol Notes
Synthetic GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) acting on pituitary GnRH receptors to release LH and FSH. The response is delivery-pattern dependent: pulsatile administration every 60-120 minutes stimulates LH/FSH, while continuous exposure downregulates the receptor and suppresses them — the same mechanism behind GnRH-agonist chemical castration. Terminal half-life is roughly 10-40 minutes. Clinical efficacy evidence comes from pump-delivered pulsatile GnRH in congenital hypogonadotropic hypogonadism; that data does not transfer to the twice-weekly subcutaneous schedule common in community use. Unlike HCG, which acts directly on testicular Leydig cells, gonadorelin acts one step higher, at the pituitary.

Why This Dosing Protocol

Why the pattern matters more than the number. Because the GnRH receptor downregulates under continuous exposure, the delivery schedule — not the milligram amount — determines whether LH and FSH go up or down. The clinical protocols that established efficacy used an infusion pump delivering physiologic pulses every 60-120 minutes.

Why community dosing is a convention, not evidence. Community protocols use microgram-scale subcutaneous injections, commonly around 100 mcg a couple of times per week. That schedule does not reproduce the pulsatile pump pattern the trial data comes from, and no controlled study has evaluated it. Treat the numbers as reported practice, not a validated dose.

Reconstitution Calculator

Dilution math and unit conversions. Prefilled using a common vial size for this peptide.

Open calculator

Storage & Handling

Storage at a glance

Proper storage temperatures, shelf life, reconstitution best practices, and travel tips for lyophilized and reconstituted peptides.

Powder: Freezer
1+ year at -20°C
Reconstituted: Fridge
4 weeks max at 2-8°C
View Complete Storage Guide

Handling specifics

Educational overview on storage, labeling, and traceability considerations for lab environments. Consult primary literature and vendor documentation for specifics.

Powder storage (very stable)
  • Freezer (-20°C): 1+ year
  • Refrigerator (2-8°C): 1-3 months
  • Room temperature: 2-3 weeks (emergency only)
Reconstituted storage (fragile)
  • MUST refrigerate at 2-8°C
  • 4-week maximum shelf life
  • NEVER freeze after reconstitution
  • Use bacteriostatic water for multi-dose
Molecular Structure

Gonadorelin sequence

Click any residue to see its properties.

HydrophobicPolarAcidic (−)Basic (+)Special

Sequence-derived properties

Length
10 residues
Molecular weight
1200.3 Da
backbone only
Avg hydrophobicity
-1.28
Kyte–Doolittle scale

Residue classes

Hydrophobic: 2 (20%)Polar: 3 (30%)Basic (+): 2 (20%)Special: 3 (30%)

Net charge distribution

Positive2 (20%)
Neutral8 (80%)
Negative0 (0%)

Amino acid frequency

G×2H×1L×1P×1Q×1R×1S×1W×1Y×1

Modifications

  • N-terminal pyroglutamate (pGlu)
  • C-terminal glycinamide (amidation)
  • Sequence identical to native GnRH

Sequence and properties provided for educational reference. Not for clinical dosing decisions.

FAQ

What is gonadorelin?

Gonadorelin is synthetic gonadotropin-releasing hormone (GnRH) — a decapeptide with the sequence pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, identical to the hormone the hypothalamus releases. It binds the GnRH receptor on gonadotroph cells in the anterior pituitary and triggers release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is very short-acting, with a distribution half-life of roughly 2-10 minutes and a terminal half-life of about 10-40 minutes.

Why does the dosing pattern change what gonadorelin does?

Because the GnRH receptor responds to rhythm, not just exposure. Pulsatile delivery — the physiologic pattern, roughly every 60-120 minutes — stimulates LH and FSH release. Continuous exposure downregulates the receptor and suppresses LH and FSH instead. That suppression is the documented mechanism behind GnRH-agonist chemical castration. The same molecule can drive the axis in either direction depending on how it is delivered, which is the single most important thing to understand about it.

How is gonadorelin different from HCG?

They act at different levels of the same cascade. HCG mimics LH and acts directly on the LH receptor of testicular Leydig cells, bypassing the pituitary entirely. Gonadorelin acts one step higher — it signals the pituitary to release its own LH and FSH. That difference means gonadorelin depends on a functioning pituitary and on an appropriate delivery pattern, while HCG does not.

What does the clinical evidence actually cover?

The efficacy evidence for GnRH comes from pump-delivered pulsatile administration in congenital hypogonadotropic hypogonadism, where an infusion pump reproduces physiologic pulses every 60-120 minutes. That is a different intervention from the twice-weekly subcutaneous injections common in community use, and the pump data should not be read as supporting that schedule. No controlled trial has evaluated the community protocol.

Is there an established community dose?

No validated one. Community protocols reference microgram-scale subcutaneous doses, commonly around 100 mcg a couple of times per week. Those figures are reported convention rather than trial-derived numbers. Because dosing is microgram-scale, a single 2 mg vial covers a large number of doses. Gonadorelin sold by research-peptide vendors is not FDA-approved and is labeled for research purposes only; this page reports what published research and community sources document, not medical advice.

How long does reconstituted peptide last?

Once mixed with bacteriostatic water, peptides remain stable for up to 4 weeks when refrigerated at 2-8°C (36-46°F). Unopened powder can last 1+ year in the freezer. Get our complete Storage & Travel Guide.

Is this peptide legal to purchase?

Peptides sold "for research purposes only" are legal to purchase in the US, but are not FDA-approved for human use outside of specific medical applications. Always consult a healthcare provider before use.

New to peptides?

Take our Peptide Match tool to find the best peptide for your goals. You can also read our Complete Guide to Peptides to learn the basics.

Gonadorelin Research Articles

Compare Gonadorelin to alternatives

Side-by-side mechanism, dose, half-life, and vendor pricing.

Open compare →

Disclosure: we may earn affiliate commission from qualifying purchases. Educational information only — not medical advice.